Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
08/11/2011 | US20110195955 Highly selective sigma receptor ligands |
08/11/2011 | US20110195954 Novel compounds |
08/11/2011 | US20110195953 Compositions and methods for treating cns disorders |
08/11/2011 | US20110195952 Treating psychological conditions using muscarinic receptor m1 antagonists |
08/11/2011 | US20110195951 Diazaindole derivatives and their use in the inhibition of c-jun n-terminal kinase |
08/11/2011 | US20110195950 Organic Compounds |
08/11/2011 | US20110195948 Substituted Pyrazolo[1,5-a]Pyrimidine Compounds as TRK Kinase Inhibitors |
08/11/2011 | US20110195936 Bicyclic sphingosine 1-phosphate analogs |
08/11/2011 | US20110195933 Pyrazolo[1,5-a]pyridines as mark inhibitors |
08/11/2011 | US20110195931 Methods and compositions for reducing neuronal cell death |
08/11/2011 | US20110195928 Administration of Copper to an Animal |
08/11/2011 | US20110195909 Novel x-conotoxin peptides (-ii) |
08/11/2011 | US20110195908 Prosaposin as a neurotrophic factor |
08/11/2011 | US20110195907 Amino acid and peptide conjugates of amiloride and methods of use thereof |
08/11/2011 | US20110195898 Treatment of alzheimer's disease and mild cognitive impairment using gnrh-i analogs and one or more of acetylcholinesterase inhibitors and nmda receptor antagonists |
08/11/2011 | US20110195156 Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
08/11/2011 | US20110195125 Nanoparticles For Drug Delivery To The Central Nervous System |
08/11/2011 | US20110195123 Methods, compositions and systems for local delivery of drugs |
08/11/2011 | US20110195122 Extended Release Formulation |
08/11/2011 | US20110195121 chronotherapeutic pharmaceutical dosage form |
08/11/2011 | US20110195117 Controlled release compositions of ropinirole |
08/11/2011 | US20110195109 Adhesive skin patch and packaged product |
08/11/2011 | US20110195095 Injectable nanoparticulate olanzapine formulations |
08/11/2011 | US20110195077 Methods and compositions using fgf23 fusion ppolypeptides |
08/11/2011 | US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS |
08/11/2011 | US20110195049 Compositions and methods for treating multiple sclerosis |
08/11/2011 | US20110195046 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
08/11/2011 | US20110195031 Methods for the use of progestogen as a glucocorticoid sensitizer |
08/11/2011 | US20110195023 Internalizing Anti-CD74 Antibodies and Methods of Use |
08/11/2011 | CA2789038A1 Selective reduction of allelic variants |
08/11/2011 | CA2789021A1 Hetaryl-[1,8]naphthyridine derivatives |
08/11/2011 | CA2788835A1 The use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with inhibitors of calcineurin or inhibitors of the mammalian target of rapamycin (mtor) complexes |
08/11/2011 | CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
08/11/2011 | CA2788493A1 Composition and method for the treatment of neuropathic pain |
08/11/2011 | CA2788416A1 Highly selective 5-ht(2c) receptor agonists having antagonist activity at the 5-ht(2b) receptor |
08/11/2011 | CA2788133A1 Method for proliferating stem cells by activating c-met/hgf signaling and notch signaling |
08/11/2011 | CA2788071A1 Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors |
08/11/2011 | CA2788032A1 Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
08/11/2011 | CA2788024A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates |
08/11/2011 | CA2785776A1 Tetrahydro-pyran derivatives against neurological illnesses |
08/10/2011 | EP2354795A1 Methods and compositions relating to Alzheimer`s disease |
08/10/2011 | EP2354141A1 (1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1h-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenrative disorders. |
08/10/2011 | EP2354136A1 Novel dopamine d3 receptor ligands, the preparation and use thereof |
08/10/2011 | EP2354124A2 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
08/10/2011 | EP2353651A2 Use of apoptosis inhibiting compounds in degenerative neurological disorders |
08/10/2011 | EP2353599A1 8-hydroxyquinolines as inhibitors of cathepsin B |
08/10/2011 | EP2353594A1 Compositions comprising tramadol and the co-crystal of celecoxib and L-proline in the treatment of pain |
08/10/2011 | EP2353591A1 Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof |
08/10/2011 | EP2352731A1 Gamma secretase modulators |
08/10/2011 | EP2352730A2 Biologically active amides |
08/10/2011 | EP2352498A1 Compositions and methods for minimizing or reversing agonist-induced desensitization |
08/10/2011 | EP2352494A1 Novel and potent tapentadol dosage forms |
08/10/2011 | EP2352492A2 Small molecule modulators of epigenetic regulation and their therapeutic applications |
08/10/2011 | EP2190815B1 Pyrrolidine aryl-ether as nk3 receptor antagonists |
08/10/2011 | EP2170873B1 Isoxazole-imidazole derivatives |
08/10/2011 | EP2137167B1 Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives |
08/10/2011 | EP2046354B1 Aphanizomenon flos aquae preparation, extracts and purified components thereof for the treatment of neurological, neurodegenerative and mood disorders |
08/10/2011 | EP1948603B1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
08/10/2011 | EP1751163B1 Benzazepine compounds having affinity for dopamine d3 receptor and uses thereof |
08/10/2011 | EP1747277B1 Gene delivery to neuronal cells |
08/10/2011 | EP1675591B1 Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an acetylcholinesterase inhibitor |
08/10/2011 | EP1674446B1 A method of preparing memantine hydrochloride |
08/10/2011 | EP1626971B1 6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines |
08/10/2011 | EP1609781B1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine |
08/10/2011 | EP1496873B2 Chewable soft capsule |
08/10/2011 | EP1465653B1 Therapeutic application of g-csf |
08/10/2011 | EP1383465B1 Acute pharmacologic augmentation of psychotherapy with d-cycloserine |
08/10/2011 | EP1190074B1 Recombinant anti-cd40 antibody and uses thereof |
08/10/2011 | EP1135513B2 Adenovirus-mediated gene therapy |
08/10/2011 | CN1972940B Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists |
08/10/2011 | CN1919272B Traditional Chinese medicine concentrated pill |
08/10/2011 | CN1129942B Aza spiro-compounds acting on the cholinergic system with muscarinic agonist activity |
08/10/2011 | CN102149721A Aminophosphinic derivatives that can be used in the treatment of pain |
08/10/2011 | CN102149700A Novel salts and polymorphs of desazadesferrothiocin polyether analogues as metal chelation agents |
08/10/2011 | CN102149698A 5-substituted benzoxazines |
08/10/2011 | CN102149697A 6-substituted benzoxazines as 5-HT-5A receptor antagonists |
08/10/2011 | CN102149689A Substituted 1-benzyl-cinnolin-4(1H)-one derivatives, preparation thereof, and therapeutic use thereof |
08/10/2011 | CN102149685A Isoquinolinone derivatives as NK3 antagonists |
08/10/2011 | CN102149681A Piperazine derivatives for binding and imaging amyloid plaques and their use |
08/10/2011 | CN102149671A Polymorphic form of rasagiline mesylate |
08/10/2011 | CN102149390A Complement antagonists and uses thereof |
08/10/2011 | CN102149386A Novel pharmaceutical composition for treating nociceptive pain |
08/10/2011 | CN102149383A Pharmaceutical agent, food or beverage having inhibitory activity on serotonin transporter |
08/10/2011 | CN102149379A Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity |
08/10/2011 | CN102146137A Antibody to beta-amyloid peptide and application thereof |
08/10/2011 | CN102146053A 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders |
08/10/2011 | CN102145156A Medicament for treating cancer pains |
08/10/2011 | CN102145128A Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof |
08/10/2011 | CN102145114A Novel traditional Chinese medicine for treating cold |
08/10/2011 | CN102145105A Extract of the family dioscoreaceae and composition for preventing or treating peripheral neuropathy comprising the same |
08/10/2011 | CN102145100A Special oral preparation for treating cervical spondylosis |
08/10/2011 | CN102145097A Traditional Chinese medicinal composition for moistening dryness |
08/10/2011 | CN102145093A Traditional Chinese medicine composition for treating schizophrenia |
08/10/2011 | CN102145082A Chinese medical composition capable of promoting blood circulation and clearing away heat |
08/10/2011 | CN102145076A Rehmannia and new use of extract of rehmannia |
08/10/2011 | CN102145074A Medicated wine with function of smoking cessation |
08/10/2011 | CN102145052A Traditional Chinese medicine composition with effect of regulating flow of qi |
08/10/2011 | CN102145051A Method for preparing heart and spleen tonifying capsules |
08/10/2011 | CN102145006A Depression resistance application of panaxoside Ppt |
08/10/2011 | CN102144991A Composition containing selegiline and transdermal patch containing composition |